Amgen, Inc. (AMGN)
467.06
-1.05
(-0.22%)
USD |
NASDAQ |
Nov 12, 16:00
469.13
+2.07
(+0.44%)
After-Hours: 04:13
Amgen Market Cap : 252.63B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 252.63B |
| November 11, 2026 | 253.20B |
| November 10, 2026 | 251.64B |
| November 09, 2026 | 251.64B |
| November 06, 2026 | 249.04B |
| November 05, 2026 | 248.97B |
| November 04, 2026 | 258.81B |
| November 03, 2026 | 249.50B |
| November 02, 2026 | 251.76B |
| October 30, 2026 | 252.11B |
| October 29, 2026 | 249.07B |
| October 28, 2026 | 244.26B |
| October 27, 2026 | 242.16B |
| October 26, 2026 | 240.37B |
| October 23, 2026 | 237.46B |
| October 22, 2026 | 241.80B |
| October 21, 2026 | 236.97B |
| October 20, 2026 | 237.29B |
| October 19, 2026 | 229.72B |
| October 16, 2026 | 233.80B |
| October 15, 2026 | 234.64B |
| October 14, 2026 | 230.36B |
| October 13, 2026 | 223.18B |
| October 12, 2026 | 225.74B |
| October 09, 2026 | 224.28B |
| Date | Value |
|---|---|
| October 08, 2026 | 220.26B |
| October 07, 2026 | 223.31B |
| October 06, 2026 | 217.65B |
| October 05, 2026 | 217.85B |
| October 02, 2026 | 217.88B |
| October 01, 2026 | 220.17B |
| September 30, 2026 | 227.87B |
| September 29, 2026 | 229.02B |
| September 28, 2026 | 226.04B |
| September 25, 2026 | 224.14B |
| September 24, 2026 | 219.51B |
| September 23, 2026 | 219.53B |
| September 22, 2026 | 221.78B |
| September 21, 2026 | 212.54B |
| September 18, 2026 | 208.48B |
| September 17, 2026 | 205.31B |
| September 16, 2026 | 203.45B |
| September 15, 2026 | 203.08B |
| September 14, 2026 | 206.24B |
| September 11, 2026 | 204.00B |
| September 10, 2026 | 206.76B |
| September 09, 2026 | 211.52B |
| September 08, 2026 | 212.55B |
| September 04, 2026 | 236.37B |
| September 03, 2026 | 240.09B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 208.43B |
| Regeneron Pharmaceuticals, Inc. | 98.35B |
| AbbVie, Inc. | 520.44B |
| Biogen, Inc. | 37.02B |
| Vertex Pharmaceuticals, Inc. | 137.57B |
Market Cap Related Metrics
| PE Ratio | 27.09 |
| PS Ratio | 6.522 |
| PEG Ratio | 0.8137 |
| Price to Book Value | 17.60 |
| Price to Free Cash Flow | 26.53 |
| Price | 467.06 |
| Earnings Yield | 3.69% |
| PEGY Ratio | 0.7648 |
| Operating PE Ratio | 18.32 |
| Normalized PE Ratio | 24.86 |